Mail & Guardian
Mail & Guardian
jenner institutelatest news & developments
The vaccine being used in the South African Ox1Cov-19 Vaccine VIDA-Trial, led by Wits Professor Shabir Madhi, is called ChAdOx1 nCoV-19. It is made from a virus called ChAdOx1, which has been engineered to express the SARS-CoV-2 spike protein. (Image via Wits University)
BHEKISISA CENTRE FOR HEALTH JOURNALISM
Video

Q&A: 9 things to know about Africa’s first Covid-19 vaccine trial

In about a year we’re likely to know if a candidate vaccine we’re beginning to test this week is effective against a virus that has devastated our country

  • Mia Malan
6 min read